# OnCo record link-cell-therapies (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/link-cell-therapies/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "link-cell-therapies" ;
  schema:name "Link Cell Therapies"@en ;
  schema:description "Link Cell Therapies makes CAR-T cells that only attack a cell when they find two cancer markers on it together, which is meant to spare healthy tissue that carries just one. Its first treatment, for advanced kidney cancer, began dosing patients in 2026."@en ;
  schema:url <https://onco.cc/companies/link-cell-therapies/>, <https://linkcelltx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://linkcelltx.com/>, <https://linkcelltx.com/link-cell-therapies-launches-with-vision-of-advancing-car-t-therapies-in-solid-and-liquid-tumors/>, <https://linkcelltx.com/link-cell-therapies-initiates-clinical-dosing-with-logic-gated-car-t-therapy-expands-executive-leadership-and-upsizes-series-a-financing-to-90-million/>, <https://clinicaltrials.gov/study/NCT07564232> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/clear-cell-rcc/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/armored-car/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/>, <https://onco.cc/companies/bms/> .